Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous route and pharmacology of metoclopramide (SOPHA-Méto)
2014-004282-25Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of metoclopramide in nausea ((none)), Vomiting and Gastroenterologic disorder (4 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Primary absolute bioavailability (overall doses). Started Jun 2015; status: completed.
02
Drugs
metoclopramide
03
Conditions
nausea ((none))VomitingGastroenterologic disorder
Beyond the preview
Go deeper on 2014-004282-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004282-25.